quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:11:34·22d
PRRelease
BioCardia Inc. logo

BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure

BCDA· BioCardia Inc.
Health Care
Original source

Companies

  • BCDA
    BioCardia Inc.
    Health Care

Recent analyst ratings

  • Dec 20UpdateHC Wainwright & Co.$9.00

Related

  • INSIDER1d
    SEC Form 4 filed by Altman Peter
  • SEC4d
    BioCardia Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR4d
    BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
  • SEC8d
    BioCardia Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC22d
    BioCardia Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • INSIDER28d
    SEC Form 4 filed by Altman Peter
  • SEC30d
    BioCardia Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC30d
    SEC Form S-8 filed by BioCardia Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022